Oral HPV infection and disease results from increases in oral-based immune suppression in the HIV co-infected individual that cannot be restored and is possibly compromised further by HAART. This review provides greater insight into the rate of oral HPV infection in the HIV + individual, the effect of HAART on oral HPV infection, it's role in oral pathology, and the host's immune response against HPV under immune compromised (HIV without effective HAART) and potentially immune restored (effective HAART) conditions.
INTRODUCTION
The human immunodeficiency virus (HIV) epidemic continues to grow at a significant rate worldwide with over 34 million people infected 1 . This disease leads to progressive immune suppression with selective depletion of CD4 + T lymphocytes. There are numerous opportunistic infections that occur secondary to this decrease in systemic immunity, particularly in the oral cavity with over 50% of HIV-infected individuals developing oral pathology 2 . One pathogen which is commonly found in both the oral and genital tracts of HIV-positive patients is the mucosatropic human papillomavirus (HPV), however infection can occur with or without mucosal pathology 3 , 4 . HPV-associated oral lesions include condyloma, focal epithelial and some squamous cell carcinomas 4 , 5 . Both oral and genital lesions caused by HPV are more commonly seen in those co-infected with HIV 6 , 7 , 8 . Systemic immune reconstitution for the HIV-positive patient has been accomplished with highly active anti-retroviral therapy (HAART) leading to decreases in systemic and oral infections, including regression in HPV-induced cervical lesions 9 , 10 . Paradoxically, recent reports have noted increases in oral pathology consistent with HPV infection in the presence of HAART 12 , 13 . If this observation can be confirmed, it suggests that the host defense against oral HPV is independent of that restored by HAART and may be adversely affected. Unfortunately, little is known about the prevalence, natural history and immune response against oral HPV infection, especially in the HIV co-infected individual. 27 . What is lacking in these studies is a detailed analysis of the exact site of HPV oral infection as well as detailed delineation of the role of HPV in abnormal or cancerous oral tissue.
HUMAN PAPILLOMAVIRUS IN ORAL DISEASE

HPV IN HIV DISEASE.
As with the HIV -population there are large differences between the infection rates with HPV and the occurrence of oral lesions 28 41 . Although recent studies have detected HPV antibodies in oral fluids 43 , these studies were cross-sectional in design and did not closely examine the HPV infectious status of the oral cavity.
CELL MEDIATED IMMUNITY
Although the incidence of HPV infection and disease is higher in patients with cellular immunodeficiencies such as renal transplant recipients and HIV + individuals 7 , 8 , the cellular immune mechanisms that control HPV infection have not been clearly elucidated. Recently, the role of systemic cytokines in the immune response to various pathogens has been investigated 44 , 45 . These studies have shown that the immune response can be characterized as a Th1 type (IL-2, IL-12, IFN-γ, IgG1 production) that is involved in control of intracellular (i.e., viral) infections, by the induction of cytolytic activity 44 . Conversely, a Th2-type response (IL-4, IL-5, IL-10, IgG4, IgA production) is functionally important against extracellular pathogens (i.e., bacteria and parasitic infections) through antibody-mediated mechanisms 44 . In HIV disease a shift in the Th1/Th2 response has been suggested during progression to AIDS, though this has proved controversial 45 . Preliminary data have shown that women with abnormal Papanicolou smears or cervical neoplasia have lower systemic IL-2 levels and higher IL-4 and IL-10 than do controls which suggests that HPV disease occurs with a relative decrease in Th1 cytokines and with a relative increase of Th2 cytokines 46 , 47 . However, no study of systemic cytokines or local mucosal cytokines in oral HPV infection has been done.
IMMUNE RESTORATION DUE TO HAART
The introduction of protease inhibitors and the development of combination highly active anti-retroviral therapy (HAART) in the late 1990's has had a profound impact on HIV disease with the associated decreases in systemic HIV viral loads and increases in CD4 + cells 9 . This has also been associated with a marked decrease in the risk of many oral opportunistic infections including oral candidiasis, Kaposis' sarcoma, major aphthous ulcers and necrotizing stomatitis 13 , 14 . Paradoxically, recent reports have noted increases in oral pathology consistent with HPV infection in the presence of HAART, which suggests that defense against oral HPV infection is independent of that restored by HAART and may be adversely effected 12 . Although, many have studied the impact of HAART on systemic immune function, relatively little is known about the reconstitution of mucosal immunity
SUMMARY
Human papillomavirus is a ubiquitous pathogen that infects mucosal surfaces especially the genital tract and oral cavity.
The current clinical observation of an increase in oral pathology due to HPV in the HIV + individual in the setting of active anti-retroviral therapy implies the lack of mucosal immune reconstitution. 
